Nokia Oyj Press Release Nokia and Celesta Capital launch Astranu to advance healthcare imaging technology Startup spin-out from Nokia Bell Labs will commercialize advanced healthcare imaging technology. Venture is the first in a Nokia – Celesta collaboration aiming to create a pipeline of spin outs from Nokia Bell Labs technologies. Astranu’s transformative technology delivers a highly performant, cost-effective imaging system for rapid and accurate 3D imaging of middle-ear conditions and hearing response. 15 May 2025 Murray Hill, New Jersey and San Mateo, California – Nokia and Celesta Capital today announced that Astranu, a company transforming hearing care through next-generation imaging technology, has officially spun out from Nokia as part of a collaboration to accelerate the commercialization of innovative technologies. This marks the inaugural venture launched through the collaboration between Nokia and Celesta Capital. Astranu leverages proprietary integrated Optical Coherence Tomography (iOCT) technology developed by Nokia Bell Labs and aims to dramatically transform ear diagnostic care through advanced, non-invasive, high-resolution 3D imaging. The iOCT technology brings high performance imaging into the world’s most cost-effective OCT system, providing instant, high-accuracy imaging of middle-ear conditions and hearing response. This has the potential to address critical healthcare gaps by helping to reduce incidences of misdiagnosis, unnecessary referrals, and significantly reducing the reliance on costly and invasive exploratory surgery and imaging techniques such as CT and MRI scans. Through the spin out, experienced healthcare technology executive Trevor Hawkins, PhD, joins Astranu as CEO, bringing decades of leadership in successfully scaling healthcare and diagnostic startups. iOCT co-inventors Michael Eggleston, PhD, and Bibek Samanta, PhD, who incubated and developed the technology to commercial readiness at Nokia Bell Labs, will help support Astranu in this next phase. Nokia Bell Labs, Nokia’s award-winning industrial research arm, will continue to support Astranu with vital laboratory resources and R&D expertise, reaffirming their commitment to fostering innovation with real world-impact. “Astranu reflects Nokia Bell Labs’ approach and commitment to nurturing groundbreaking innovations from early-stage research through commercialization. Astranu’s revolutionary imaging technology holds transformative promise for healthcare, and we’re proud to support their journey,” said Mike Chen, Vice President of Ventures at Nokia. Story Continues Celesta Capital’s involvement brings strategic direction, commercialization support, and substantial industry networks vital for rapid market adoption of Astranu’s technology. “We are excited to partner with Nokia in spinning out Astranu, which represents the ideal convergence of innovative technology and high impact healthcare applications. Celesta’s experience in scaling deep technology ventures uniquely positions us to help Astranu navigate the complex dynamics of establishing and scaling a successful technology business,” said Sriram Viswanathan, Founding Managing Partner at Celesta Capital. Achin Bhowmik, PhD, Chief Technology Officer and Executive Vice President of Engineering for hearing technology company Starkey, will join the Company’s Board of Directors. “Astranu’s imaging technology offers the potential to deliver high-resolution insights at the point of care,” said Dr. Bhowmik. “I look forward to supporting the company’s journey and helping explore ways this technology can advance patient outcomes.” About Nokia At Nokia, we create technology that helps the world act together. As a B2B technology innovation leader, we are pioneering networks that sense, think and act by leveraging our work across mobile, fixed and cloud networks. In addition, we create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs, which is celebrating 100 years of innovation. With truly open architectures that seamlessly integrate into any ecosystem, our high-performance networks create new opportunities for monetization and scale. Service providers, enterprises and partners worldwide trust Nokia to deliver secure, reliable and sustainable networks today – and work with us to create the digital services and applications of the future. About Celesta Capital Celesta Capital is a global deep technology venture capital firm. Led by technology industry veterans with decades of investment and operational experience, Celesta Capital has a passion and proven track record for building and scaling global businesses. Founded in 2013, Celesta has a portfolio of more than 100 early-stage technology investments. Learn more at http://celesta.vc. Media contacts Nokia Press Office Email: [email protected] Celesta Capital Trevor DeWitt, Head of Marketing Email: [email protected] Follow us on social media LinkedInXInstagramFacebookYouTube Connect with Celesta LinkedInXNewsletterTechSurge Podcast View Comments
Nokia and Celesta Capital launch Astranu to advance healthcare imaging technology
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...